Guillaume Lessene

32PUBLICATIONS
149CO-AUTHORS
Medical devicesMolecular targetsMedical infection agents (incl. prions)PharmacogenomicsNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|May 29, 2026
The benchmarking and application of tag-degraders in vivo to validate therapeutic targets.

|Apr 09, 2025
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.

Jia-Nan Gong, Tirta M Djajawi, Donia M Moujalled

|Apr 03, 2025
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.

Stefanie M Bader, Dale J Calleja, Shane M Devine

|Mar 05, 2025
Differential regulation of BAX and BAK apoptotic activity revealed by small molecules.

Kaiming Li, Yu Q Yap, Donia M Moujalled

|Jul 23, 2024
Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape.

Xinyu Wu, Margareta Go, Julie V Nguyen

|Feb 13, 2023
From (Tool)Bench to Bedside: The Potential of Necroptosis Inhibitors.

Christopher R Gardner, Katherine A Davies, Ying Zhang

Pageof 6

Frequent Collaborators

8 joint publications

Marco J Herold

8 joint publications

Andreas Strasser

7 joint publications

Peter E Czabotar

6 joint publications

James M Murphy